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The aim of the investigation was to evaluate the diagnostic value of the study serum and urinary contents of γ-glutamyl transpeptidase 
(GGTP) in newborns with impaired renal function due to asphyxia.
Materials and Methods. Investigation included 200 full-term newborns with disturbance kidney function: 100 infants who had severe 
asphyxia, and 100 — with moderate asphyxia. Comparison group consisted of 20 healthy children without asphyxia. The peripheral venous 
blood and urine of newborns were picked up by 1–2, 7–8 and 25–30 days of life. GGTP activity was determined by a standardized method of 
“endpoint” after rate of formation of 5-amino-2-nitrobenzoate at 405 nm and 37°C on the semi-automatic photometer using reagents of Olvex 
Company (Russia).
Results. Disturbance kidney function in neonates with asphyxia causes a significant increase the level of GGTP in serum and urine in the 
first 24–48 hours after birth. Enzyme concentration in biological fluids during this period in the groups of surveyed children was the highest. In 
the dynamics of the early neonatal period marked reduction of GGTP in serum and urine in children with kidney dysfunction due to asphyxia. 
By the end of the neonatal period the enzyme content in serum and urine in neonates with asphyxia and disturbance kidney function remained 
high. In infants with renal impairment due to moderate asphyxia during the first weeks of life ratio of serum/urine GGTP content decreased less 
than 2.5 relative to the comparison group, followed its raised to 25–30 days of life. At the same time, infants with severe renal impairment due 
to asphyxia were characterized by high rates ratio (greater than 4.0) during the whole neonatal period. In the examined groups of children during 
the early neonatal period indicated a statistically significant positive moderate correlation between the serum and urinary GGTP content.
Conclusion. Serum GGTP activity is characterized severity of cytolysis syndrome of proximal renal tubular epithelium in neonates with 
disturbance kidney function due to asphyxia. Noninvasive determination of GGTP levels in the urine in the early neonatal period, preferably for 
the screening of renal problems in neonates with asphyxia.
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The assessment of organospecific enzyme content 
in biological fluids enables to determine localization 
and intensity of kidney damage [1]. This is of special 
importance in asphyxia in newborns as it may influence 
the tactics of managing the patients. 
One of the enzymes specific for renal tissue is gamma-
glutamyl transpeptidase (γ-glutamyl transferase, GGTP). 
This enzyme catalyses the transfer of γ-glutamyl group 
from a peptide or a compound, containing this group, to 
an acceptor peptide or amino acid [2].
GGTP is found in the cell membranes, possessing 
high secretory or absorption capability. The epithelium 
of proximal kidney tubules is known to have the 
highest activity. Despite of this fact, this enzyme is 
not practically identified in the urine of healthy people 
because of a high molecular weight. The increase of 
its concentration in urine is noted in patients with acute 
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infectious diseases of the urine system and conditions, 
which are accompanied by a significant destruction of 
the renal tissue [2, 3].
The period of GGTP half-life in the blood serum 
is 7–10 days, and may increase to 28 days in case of 
enzyme clearance disturbance. Owing to this and a high 
organospecificity relative to the renal tissue, GGTP may 
be used for diagnosing kidney damage [4], including 
newborns.
Besides, this enzyme may be a marker of an oxidative 
stress. A high level of GGTP induces the reduction of 
glutathione provision, which enhances free radical 
production and provokes an oxidative stress [5]. The 
latter is one of the key elements of asphyxia at birth [6]. 
Nevertheless, a problem of diagnostic value of GGTP in 
kidney function impairment in neonates with asphyxia 
remains unstudied.
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The aim of the investigation is to assess a diagnostic 
value of γ-glutamyl transpeptidase content in the blood 
serum and urine of the neonates with kidney dysfunction 
due to asphyxia.
materials and methods. 200 full-term newborns with 
the signs of renal damage were investigated. Infants 
were divided into two groups: group 1 (n=100) — 
neonates suffered severe asphyxia, group 2 (n=100) — 
babies suffered moderate asphyxia. A comparison 
group comprised 20 infants without asphyxia at birth, 
which were being examined and treated at the in-patient 
department because of other problems.
A sampling method was used in the investigation. 
Newborns with other diseases, aggravating their 
condition, were excluded from it, e.g. polycythemia, 
hemolytic and hemorrhagic diseases, acute surgical 
pathology, requiring correction in the neonatal period, 
purulent meningitis, neonatal pneumonia, urinary 
tract infection, congenital abnormalities of the heart, 
gastrointestinal tract or kidneys, arrhythmias in neonatal 
period, multiple congenital defects, chromosome 
abnormality. Additionally, babies with conjugated 
jaundice, hepatic pathology, as well as infants born from 
the parents consuming alcohol, as the level of enzyme 
in the serum in this case might not be caused by renal 
reasons, were also excluded from the study [2]. The 
examined groups did not contained infants with hypoxic 
myocardial damage in order to exclude the influence of 
cardiac causes on the GGTP values [1, 2].
The study complies with the Declaration of Helsinki 
(the Declaration was passed in Helsinki, Finland, June, 
1964, and revised in October, 2000, Edinburg, Scotland) 
and was performed following approval by the Ethic 
Committee of Sumy State University. Written informed 
consent was obtained from the parents of the newborns.
Kidney dysfunction was diagnosed, if the level of 
blood creatinine was higher than 89 μmol/L, blood 
urea — higher than 8 mmol/L, urine output dropped 
lower than 1 ml/kg/h [7]. The diagnosis of moderate 
and severe asphyxia was established according to the 
“Protocol of initial resuscitation and post-resuscitation aid 
to newborns” (Order of the Ministry of Health of Ukraine 
of June 08, 2007, No.312).
Diagnostic criteria of severe asphyxia at birth were: 
Apgar assessment lower than 4 scores during the 
first 5 minutes of life; clinical symptoms of heavy CNS 
damage, which appeared in the first 72 hours of life; 
signs of impairment of one more vital organ or system 
(respiratory, cardio-vascular, urinary, gastro-intestinal 
and so on) during the first 3 days of life; metabolic or 
mixed acidosis (pH<7.0 and/or base deficiency more 
than 12 mmol/L) in the cord blood.
Diagnostic criteria of moderate asphyxia at birth were 
the following: less than 7 scores according to Apgar 
scale during the first 5 minutes; clinical symptoms of 
moderate  CNS damage, which occurred in the first 
72 hours of life; signs of transitory disturbance of one of 
the vital organ or system (respiratory, cardio-vascular, 
urinary, gastro-intestinal and so on) during the first 3 
days of life; metabolic or mixed acidosis (pH<7.15 and/or 
base deficiency more than 12 mmol/L) in the cord blood. 
If it was technically impossible to estimate an acid-base 
balance of the neonate’s blood, the diagnosis of asphyxia 
at birth was based on the first three signs.
The material for investigation was a peripheral venous 
blood of the newborns with the signs of kidney impairment 
caused by asphyxia. Blood was taken fasting in the 
morning to avoid the influence of daily fluctuations and 
food intake on the enzymemia level. Blood was collected 
on the 1–2 day of life, at the end of the early neonatal 
period (7–8 day of life), and at the end of the first month 
(25–30 day). Peripheral venous blood, remained after 
laboratory test necessary for evaluating infant condition 
after asphyxia, was used for the investigation.
To determine the activity of enzymes in the urine, it 
was collected into sterile urinals after the cleaning of 
external genital organs. In order to exclude the influence 
of diurnal rhythms on the excretion of urinal enzymes, an 
early urine portion, collected between 8 and 10 o’clock, 
was examined 
GGTP activity was determined by a standard 
“endpoint” method, considering the rate of forming 
5-amino-2-nitrobenzoate at 405 nm wavelength and 
37°C, using a semi-automatic photometer and reagents, 
produced by Olvex Company (Russia).
Statistical processing of the investigation findings 
was performed by means of Excel and Statistica 6.0 
programs. Methods of variation statistics suitable for 
medico-biological investigations were used here [8]. 
Data were presented as the mean (M), standard error of 
the mean (m), and confidence interval (CI). A calculation 
of ratio coefficients of GGTP content in the blood serum 
and urine in newborns was made to make a diagnostic 
value of determining enzyme levels in the biological 
fluids higher. Spearman rank correlation coefficient was 
used to estimate the correlation between the variables. 
As the data did not correspond to the normal law of 
distribution, index of confidence (p) was found using 
Wilcoxon criterion.
results. In the examined infants of the comparison 
group the value of GGTP in blood serum was within the 
reference intervals (0–23 nmol/(s·L) during the whole 
first month of life. Besides, it was zero in 25, 15, and 
30% of healthy newborns on the 1–2, 7–8, and 25–30 
day of life, respectively.
In infants with kidney damage asphyxia causes 
significant elevation of GGTP level in blood serum in the 
first 24–48 hours after birth. Concentration of the enzyme 
in the given time interval was the highest in the groups of 
the examined infants over the period of observation, and 
exceeded this parameter 7 times or more in newborns 
with renal dysfunction after moderate asphyxia and 
over 17 times in severe asphyxia and kidney damage in 
comparison with healthy neonates (Table 1).
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T a b l e  1
GGTp content in blood serum of full-term newborns (m±m) and confidence interval (Ci), nmol/(s·l)
Newborns
Life period
1–2 day 7–8 day 25–30 day 
Comparison group (n=20)  16.44±2.96 
 10.24–22.64
  15.16±2.04  
 10.88–19.43
 13.06±2.74 
  7.31–18.81
With kidney damage due to moderate 
asphyxia (n=100) 
   129.14±5.27  
  118.56–139.73
р
  100.17±6.63  
  86.85–113.49
р, р2
  67.04±5.93  
  55.13–78.95
р, р2, р3
With kidney damage due to severe 
asphyxia (n=100) 
  282.11±12.09 
 257.82–306.39
р, р1
    226.09±8.57  
  208.88–243.31
р, р1, р2
   163.45±5.73  
  151.93–174.98
р, р1, р2, р3
N o t e s: p — statistical significance of the value difference relative to the comparison group; p1 — 
relative to newborns with moderate asphyxia; p2 — relative to 1–2 days of life; p3 — relative to 7–
8 days of life. M±m values are given in the numerator, CI values — in the denominator.
T a b l e  2
GGTp content in the urine of the full-term newborns (m±m) and confidence interval (Ci), nmol/(s·l)
Newborns
Life period
1–2 day 7–8 day 25–30 day 
Comparison group (n=20) 5.87±1.10
3.56–8.17
4.21±0.77
2.60–5.82
4.13±0.70
2.66–5.60
With kidney damage due to moderate 
asphyxia (n=100) 
 52.94±2.95 
47.03–58.86
р
  40.80±2.47 
 35.84–45.77
р, р2
16.06±0.52
5.57–7.64
р, р2, р3
With kidney damage due to severe 
asphyxia (n=100) 
  65.38±4.47 
 56.39–74.36
р, р1
 55.37±4.89 
 45.55–65.19
р, р1
  25.28±2.69  
 19.88–30.68
р, р1, р2, р3
N o t e s: p — statistical significance of the value difference relative to the comparison group; p1 — 
relative to newborns with moderate asphyxia; p2 — relative to 1–2 days of life; p3 — relative to 7–
8 days of life. M±m values are given in the numerator, CI values — in the denominator.
T a b l e  3
ratio coefficients of GGTp content in the blood serum 
and urine in the newborns
Newborns
Life period
1–2 day 7–8 day 25–30 day 
Comparison group (n=20) 2.80 3.60 3.16
With kidney damage due  
to moderate asphyxia (n=100)
 
2.44
 
2.46
 
4.17
With kidney damage due  
to severe asphyxia (n=100)
 
4.31
 
4.08
 
6.47
During the early neonatal period reduction of serum 
GGTP content in both groups of infants by 20% 
was noted, though statistical difference in enzyme 
concentration between the groups remained.
By the end of the neonatal period further statistically 
significant decrease of GGTP in the serum continued, 
however its content remained high compared to the 
healthy babies. Besides, GGTP concentration was 2.5 
times higher in infants with renal impairment due to 
severe asphyxia than in those with moderate asphyxia. 
Among the neonates of the comparison group GGTP 
content in the urine was found only in 75% on the 1–2 
day of life, in 80% — on the 7–8 day, and in 85% — by 
the end of the neonatal period. An average enzyme level 
in the urine of the healthy newborns remained stable 
during the first month of life.
Maximum enzymuria in the newborns with kidney 
damage due to asphyxia was noted on the 1–2 day of 
life in both groups (Table 2). The highest value was in 
those infants who suffered severe asphyxia. Later on 
statistically significant decrease of enzyme concentration 
in the urine of all infants took place, but the difference 
among the groups of newborns with kidney damage due 
to severe and moderate asphyxia remained. Notably, 
that by the end of the neonatal period the level of GGTP 
in the urine of both examined groups remained high, 
being 4 and 6 times the value of the comparison group in 
moderate and severe asphyxia, respectively.
In the newborns with renal impairment due to moderate 
asphyxia decrease of ratio coefficients of GGTP levels in 
the blood serum and urine is noted during the first week 
of life relative to the comparison group with the following 
rise on the 25–30 day of life (Table 3). At the same 
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time, high coefficients during the whole 
neonatal period are characteristic of the 
neonates with renal impairment due to 
severe asphyxia.
A statistically significant positive 
moderate correlation between serum 
and urinary GGTP content is noted in the 
examined groups of infants as well as 
in the healthy neonates during the early 
neonatal period (Table 4). A significant 
relationship between these values 
disappears in all infants by the end of the 
first month of life.
discussion. Revealing GGTP in the blood serum of 
the healthy newborns is likely to be connected with some 
extrarenal sources [1, 2, 9]. Presence of this enzyme in 
the urine of the healthy babies can be explained by its 
localization in the brush border of the tubular epithelium. 
And in the process of cytoplasmatic membrane 
regeneration it may appear in the urine [10].
The increase of GGTP level in blood serum is a 
characteristic feature of acute renal damage and 
oxidative stress [6, 11]. In the course of the investigation 
it was established, that growth of GGTP serum activity is 
noted rather early in the newborns with kidney damage 
with underlying asphyxia. Already in the first 24–48 hours 
after birth a high serum level of GGTP is characteristic 
for all newborns with asphyxia and renal dysfunction. It 
reaches the highest values in severe asphyxia.
Significant enzymemia is associated with a high 
rate of enzyme release from the cells of proximal renal 
tubules due to the damage of the cellular membrane 
caused by ischemia — reperfusion [12]. Taking into 
account a cytosolic localization of the enzyme [2, 10], it 
should be understood, that only significant destruction of 
the membrane or cell death will cause the increase of its 
concentration in blood serum.
Determination of the given enzyme activity in serum 
may characterize not only the presence of oxidative 
stress, but the degree of intensity of nephrothelium 
cytolysis syndrome [10]. The findings of the given 
investigation allow to state, that cytolysis syndrome is 
most intensive in neonates with kidney damage caused 
by severe asphyxia. In the dynamics of the neonatal 
period the reduction of its manifestation is noted, however 
GGTP level in the serum does not reach normal values 
even by the end of the first month of life.
Thus, a high GGTP level in the serum has been 
proved by the authors to be an early indicator of the 
injury of the proximal tubular epithelium in newborns with 
kidney damage due to asphyxia.
Enzymuria is also a marker of renal dysfunction [13]. 
As about 2/3 of GGTP are localized in the brush border 
of the nephron proximal convoluted tubules, injury of 
these particular parts is accompanied by the appearance 
of enzymuria [2, 14]. Nearly 1/3 of the enzyme has 
intracellular localization in the Golgi complex and 
lysosomes [2, 10], therefore, to the author’s opinion, a 
high activity of GGTP in the urine is supposed to be an 
evidence of the marked damage of the epithelial cells of 
the renal tubules due to asphyxia at birth.
High enzymuria in the early neonatal period in 
newborns with kidney damage caused by asphyxia is 
most likely to be caused by ischemia of the renal tissue, 
dysfunction of the cellular membranes, and passage into 
the urine the enzymes not only of the brush border but 
intracellular ones as well. By the end of the neonatal 
period the content of GGTP in the urine becomes lower 
in the neonates with asphyxia and kidney impairment 
and this, most probably, is connected with the brush 
border remaining unstable.
Urine GGTP, in addition, is an early marker of the 
damage as its level increases already on the 1–2 day. But 
as opposed to the serum enzyme its identification in the 
urine has a significant advantage — noninvasiveness, 
which is of special importance in newborns in the 
critical state [15, 16]. Therefore, the assessment of 
GGTP activity in the urine may be used in the neonatal 
intensive therapy units for laboratory confirmation of 
kidney impairment in newborns with asphyxia.
A combination of high enzymemia and enzymuria in the 
majority of infants with kidney damage due to asphyxia 
is associated with a significant dysfunction of the apical 
and basal membranes of renal tubular epytheliocytes, 
which results in the passage of the enzyme not only in 
the urine but in the serum as well.
Calculation of ratio coefficients of serum GGTP/urine 
GGTP allows to raise the diagnostic value of neonatal 
examination (See Table 3). The coefficient below 2.5 in 
the early neonatal period typical for the newborns with 
kidney dysfunction due to moderate asphyxia seems 
to reflect relative predominance of enzymuria with 
underlying structural, functional and metabolic disorders 
of the epithelium brush border of the nephron proximal 
part. The coefficient value of more than 4.0 characteristic 
of the newborns with kidney damage caused by severe 
asphyxia is the result of relatively high enzymemia 
due to instability of the basal membrane of the tubular 
epithelium.
Availability of the significant positive correlation 
between the values of GGTP activity in the serum and 
T a b l e  4
spearman’s correlation coefficient of GGTp content in blood serum  
and urine during the neonatal period
Period of life
Newborns  
with kidney damage due 
to severe asphyxia
Newborns  
with kidney damage due 
to moderate asphyxia 
Comparison  
group
1–2 day 0.610
р=0.000
0.423
р=0.002
0.660
р=0.002
7–8 day 0.499
р=0.0002
0.544
р=0.013
0.526
р=0.017
25–30 day 0.187 0.149 0.247
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urine in the newborns with kidney damage caused by 
asphyxia in the early neonatal period (See Table 4) 
speaks of the fact, that GGTP of the urine can with a 
great degree of confidence reflect serum enzyme level in 
an infant. As the level of GGTP in the urine increases prior 
to proteinuria and elevation of serum creatinine content 
[17, 18], preference should be given to noninvasive 
identification of GGTP level in the urine in diagnosing 
kidney damage in newborns with asphyxia. This 
method may be used as a screening technique, as the 
investigation is simple, inexpensive and reproducible.
Conclusion. Noninvasive identification of GGTP 
in the urine in the early neonatal period is a preferable 
method for screening kidney damage in newborns with 
asphyxia. Increase of GGTP serum activity is a marker, 
enabling to assess the intensity of epithelium cytolysis 
syndrome of the proximal kidney tubules in newborns 
with kidney damage caused by asphyxia.
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